Several DNA mutations in the NEU1 gene in patients with sialidosis have been reported2,11, with these mutations inducing alterations in the activity of sialidase, lysosomal localization, complex formation, structure, and half-life of NEU1 polypeptides12–14, thus leading to a significant impact on the symptoms of the disease. This evidence concerns the gene NEU1 and sialidosis.